Active substanceFramicetinFramicetin Similar drugsTo uncover Isofra spray nazal. Bouchard-Recordati Laboratories France Dosage form: & nbspnasal spray Composition: Per 100 ml: Active substance: Framicetin sulfate 1.25 g, which corresponds to 800,000 YE Excipients: Methylparahydroxybenzoate 0.100 gSodium chloride 0.756 g Sodium citrate 0.106 g Citric acid monohydrate 0.040 g Water purified to 100 ml Description:Transparent colorless liquid. Pharmacotherapeutic group:Antibiotic from the group of aminoglycosides ATX: & nbspR.01.A.X Other drugs for topical use in diseases of the noseR.01.A.X.08 Framicetin Pharmacodynamics: Antibiotic from the aminoglycoside group for topical application in otolaryngology. It is bactericidal. Active for most Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae), causing the development of infectious processes in the upper respiratory tract. Indications: As part of combination therapy for infectious and inflammatory diseases of the upper respiratory tract, including: rhinitis; rhinopharyngitis;sinusitis (in the absence of damage to partitions). Preventive maintenance and treatment of inflammatory processes after surgical interventions. Contraindications: Hypersensitivity to framicetin and other antibiotics from the aminoglycoside group. The drug should not be used to flush the paranasal sinuses.Pregnancy and the period of breastfeeding. Pregnancy and lactation: Contraindicated in pregnancy and during breastfeeding. Dosing and Administration: Adults: one injection in each nostril 4-6 times a day. For children: one injection every nostril 3 times a day. Duration of treatment - no more than 7 days. When using the bottle should be kept in a vertical position. Side effects: Allergic reactions are possible. Overdose: Due to the low degree of absorption in the systemic blood flow, an overdose is unlikely. Interaction: Clinically significant drug interactions with other drugs have not been identified. Special instructions:FROMIt is worth remembering that the emergence of resistant strains of microorganisms is possible during treatment. Form release / dosage: The nasal spray is 1.25%. Packaging:15 ml per polyethylene opaque bottles with a spray tip with polyethylene screw cap. One bottle together with the instruction for use is placed in a cardboard box. Storage conditions:Store at a temperature not exceeding 25 ° C. Keep out of the reach of children. Shelf life: 3 years. Do not use after the expiration date stated on the package Terms of leave from pharmacies:On prescription Registration number:П N015454 / 01 Date of registration:15.12.2008 / 09.02.2016 Expiration Date:Unlimited The owner of the registration certificate:Bouchard-Recordati LaboratoriesBouchard-Recordati Laboratories France Manufacturer: & nbspLaboratoires BOUCHARA-RECORDATI France Representation: & nbspRUSFIK LLC RUSFIK LLC Russia Information update date: & nbsp09.11.2017 Illustrated instructions × Illustrated instructions Instructions